Project Details
Description
Produce a cost:benefit report outlining the costs of owning a PhysioMimix® OOC System (from CN Bio), versus the qualitative benefits and potential quantitative economic returns of more accurately predicting human drug-induced liver injury risk and its mechanism of action using two case study examples.
| Short title | SCR HEIF 2024 |
|---|---|
| Acronym | SCR HEIF 2024 |
| Status | Active |
| Effective start/end date | 12/08/24 → 28/03/25 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.